Literature DB >> 34326483

Phenotypic screening system using three-dimensional (3D) culture models for natural product screening.

Hikaru Suenaga1, Noritaka Kagaya2, Manabu Kawada3,4, Daisuke Tatsuda4, Toshiro Sato5, Kazuo Shin-Ya6,7.   

Abstract

Recent progress in three-dimensional (3D) cell culture systems has attracted much attention in the fields of basic life science and drug development. Newly established methods include 3D co-culture, spheroid culture, and organoid culture; these methods enable more human tissue-like culture and have largely replaced traditional two-dimensional (2D) monolayer culture. By combining 3D culture methods with high-content imaging analysis, it is possible to obtain diverse and convincing data even during initial screening (which requires rapid and easy operating procedures). Until recently, 3D culture methods were considered expensive, time-consuming, complex, and unstable. However, by exploiting the self-assembling nature of cells and adding several technical improvements, we have developed several phenotypic screenings aimed at discovering anticancer compounds.
© 2021. The Author(s), under exclusive licence to the Japan Antibiotics Research Association.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34326483     DOI: 10.1038/s41429-021-00457-8

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  49 in total

1.  Nerve cells in culture: the extraordinary discovery by Ross Granville Harrison.

Authors:  B H Gähwiler
Journal:  Brain Res Bull       Date:  1999 Nov-Dec       Impact factor: 4.077

2.  Sydney Ringer; physiological saline, calcium and the contraction of the heart.

Authors:  David J Miller
Journal:  J Physiol       Date:  2004-01-23       Impact factor: 5.182

3.  The growth in vitro of single isolated tissue cells.

Authors:  K K SANFORD; W R EARLE; G D LIKELY
Journal:  J Natl Cancer Inst       Date:  1948-12       Impact factor: 13.506

Review 4.  How were new medicines discovered?

Authors:  David C Swinney; Jason Anthony
Journal:  Nat Rev Drug Discov       Date:  2011-06-24       Impact factor: 84.694

Review 5.  Stem cell signature in glioblastoma: therapeutic development for a moving target.

Authors:  Ichiro Nakano
Journal:  J Neurosurg       Date:  2014-11-14       Impact factor: 5.115

6.  Hypoxia-induced epithelial to mesenchymal transition in cancer.

Authors:  Robert Y Hapke; Scott M Haake
Journal:  Cancer Lett       Date:  2020-05-26       Impact factor: 8.679

7.  A 3D human neural cell culture system for modeling Alzheimer's disease.

Authors:  Young Hye Kim; Se Hoon Choi; Carla D'Avanzo; Matthias Hebisch; Christopher Sliwinski; Enjana Bylykbashi; Kevin J Washicosky; Justin B Klee; Oliver Brüstle; Rudolph E Tanzi; Doo Yeon Kim
Journal:  Nat Protoc       Date:  2015-06-11       Impact factor: 13.491

8.  Visualization and targeting of LGR5+ human colon cancer stem cells.

Authors:  Mariko Shimokawa; Yuki Ohta; Shingo Nishikori; Mami Matano; Ai Takano; Masayuki Fujii; Shoichi Date; Shinya Sugimoto; Takanori Kanai; Toshiro Sato
Journal:  Nature       Date:  2017-03-29       Impact factor: 49.962

9.  A three-dimensional human neural cell culture model of Alzheimer's disease.

Authors:  Se Hoon Choi; Young Hye Kim; Matthias Hebisch; Christopher Sliwinski; Seungkyu Lee; Carla D'Avanzo; Hechao Chen; Basavaraj Hooli; Caroline Asselin; Julien Muffat; Justin B Klee; Can Zhang; Brian J Wainger; Michael Peitz; Dora M Kovacs; Clifford J Woolf; Steven L Wagner; Rudolph E Tanzi; Doo Yeon Kim
Journal:  Nature       Date:  2014-10-12       Impact factor: 49.962

10.  Amyloid-β42/40 ratio drives tau pathology in 3D human neural cell culture models of Alzheimer's disease.

Authors:  Sang Su Kwak; Kevin J Washicosky; Emma Brand; Djuna von Maydell; Jenna Aronson; Susan Kim; Diane E Capen; Murat Cetinbas; Ruslan Sadreyev; Shen Ning; Enjana Bylykbashi; Weiming Xia; Steven L Wagner; Se Hoon Choi; Rudolph E Tanzi; Doo Yeon Kim
Journal:  Nat Commun       Date:  2020-03-13       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.